• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDR
Click for more information
16.0% 29.0¢

MEDADVISOR LIMITED - News & Media

Market Cap $215.0M  ! watchlist Created with Sketch. Add to my watchlist

MedAdvisor Limited is an Australia-based company that is engaged in digital medication... MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Company's segments include Australia, the United States, the United Kingdom and Asia Operations. The Company's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
29.0¢ 		Change
0.040(16.0%) 		Mkt cap ! $215.0M
Open High Low Value Volume
26.0¢ 30.5¢ 25.0¢ $313.4K 1.109M

Buyers (Bids)

No. Vol. Price($)
2 71181 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 164948 1
View Market Depth
Last trade - 15.57pm 14/11/2024 (20 minute delay) ?
Last
28.5¢ 		  Change
0.040 ( 14.0 %)
Open High Low Volume
25.5¢ 29.5¢ 25.5¢ 132415
Last updated 15.48pm 14/11/2024 ?
MDR (ASX) Chart

Top Stories

Yangibana 33% complete says Hastings, as it provides clarification on funding

Hastings Technology Metals Ltd has provided an update on how development of the Yangibana project in Western Australia is progressing
HotCopper reacts as Resolute Mining told to pay US$160M if it wants its CEO back According to a report from Bloomberg, it appears Resolute Mining (ASX:RSG) CEO Terry Holohan is effectively being held ransom for US$160M.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Recce scores $6.75M R&D rebate Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.
Biome reaches intellectual property milestone in strain development program Biome Australia Ltd has achieved an important milestone in development of a biome strain, preparing for a transfer of intellectual property
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.